INX-315
INX-315 is a selective, orally bioavailable CDK2 inhibitor. It demonstrates anticancer activity by inducing cell cycle arrest, senescence, and suppressing E2F-driven transcription, validated in models of CCNE1-amplified cancers and CDK4/6 inhibitor-resistant breast cancer.
Product Specifications
CAS Number
2745060-92-6
Field of Research
Cell Biology
Purity
99.88% (May vary between batches)
Solubility
DMSO:80 mg/mL (187.14 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:3.3 mg/mL (7.72 mM)
Smiles
O=C1NNC2=CC=3C=NC (=NC3N2C14CCCCC4) NC5=CC=C (C=C5) S (=O) (=O) N
Molecular Formula
C19H21N7O3S
Molecular Weight
427.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2063709-01 0.1 mL
APC/CY7-Linked Polyclonal Antibody to Glial Cell Line Derived Neurotrophic Factor Receptor Alpha 2 (GFRa2)
Sign In for Pricing
View Details MBS2063709-02 0.2 mL
APC/CY7-Linked Polyclonal Antibody to Glial Cell Line Derived Neurotrophic Factor Receptor Alpha 2 (GFRa2)
Sign In for Pricing
View Details MBS2063709-03 0.5 mL
APC/CY7-Linked Polyclonal Antibody to Glial Cell Line Derived Neurotrophic Factor Receptor Alpha 2 (GFRa2)
Sign In for Pricing
View Details MBS2063709-04 1 mL
APC/CY7-Linked Polyclonal Antibody to Glial Cell Line Derived Neurotrophic Factor Receptor Alpha 2 (GFRa2)
Sign In for Pricing
View Details